152
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Application of Quality by Design for the Optimization of an HPLC Method to Determine Ezetimibe in a Supersaturable Self-Nanoemulsifying Formulation

, , &

References

  • Sweetman, S. C. Martindale: The Complete Drug Reference, Pharmaceutical Press: London, 2009.
  • Brittain, H. G. Profiles of Drug Substances, Excipients and Related Methodology, Academic Press: London, 2009.
  • Porter, C. J.; Pouton, C. W.; Cuine, J. F.; Charman, W. N. Enhancing Intestinal Drug Solubilisation Using Lipid-Based Delivery Systems. Adv. Drug Del. Rev. 2008, 60 (6), 673–691.
  • Bandyopadhyay, S.; Katare, O.; Singh, B. Development of Optimized Supersaturable Self-Nanoemulsifying Systems of Ezetimibe: Effect of Polymers and Efflux Transporters. Expert Opin. Drug Del. 2014, 11 (4), 479–492.
  • Thomas, N.; Holm, R.; Garmer, M.; Karlsson, J. J.; Müllertz, A.; Rades, T. Supersaturated Self-Nanoemulsifying Drug Delivery Systems (Super-SNEDDS) Enhance the Bioavailability of the poorly Water-Soluble Drug Simvastatin in Dogs. AAPS J. 2013, 15 (1), 219–227.
  • Xiao, L.; Yi, T. Mechanisms of Hydroxypropyl Methylcellulose for the Precipitation Inhibitor of Supersaturatable Self-Emulsifying Drug Delivery Systems. Yao Xue Xue Bao 2013, 48 (5), 767–772.
  • Varghese, S. J.; Ravi, T. K. Determination of Rosuvastatin and Ezetimibe in a Combined Tablet Dosage Form Using High-Performance Column Liquid Chromatography and High-Performance Thin-Layer Chromatography. J. AOAC Int. 2010, 93 (4), 1222–1227.
  • Hammouda, M. E.; Abu El-Enin, M. A.; El-Sherbiny, D. T.; El-Wasseef, D. R.; El-Ashry, S. M. Microemulsion Liquid Chromatographic Method for Simultaneous Determination of Simvastatin and Ezetimibe in Their Combined Dosage Forms. J. Anal. Method. Chem. 2013, 132836.
  • Patel, A.; Macwana, C.; Parmar, V.; Patel, S. Simultaneous Determination of Atorvastatin Calcium, Ezetimibe, and Fenofibrate in a Tablet Formulation by HPLC. J. AOAC Int. 2012, 95 (2), 419–423.
  • Lotfy, H. M.; Aboul Alamein, A. M.; Hegazy, M. A. Quantitative Analysis of the Cholesterol-Lowering Drugs Ezetimibe and Simvastatin in Pure Powder, Binary Mixtures, and a Combined Dosage Form by Spectrophotometry, Chemometry, and High-Performance Column Liquid Chromatography. J. AOAC Int. 2010, 93 (6), 1844–1855.
  • Hefnawy, M.; Al-Omar, M.; Julkhuf, S. Rapid and Sensitive Simultaneous Determination of Ezetimibe and Simvastatin from Their Combination Drug Products by Monolithic Silica High-Performance Liquid Chromatographic Column. J. Pharm. Biomed. Anal. 2009, 50 (3), 527–534.
  • Goel, A.; Baboota, S.; Sahni, J. K.; Srinivas, K. S.; Gupta, R. S.; Gupta, A.; Semwal, V. P.; Ali, J. Development and Validation of Stability-Indicating Assay Method by UPLC for a Fixed Dose Combination of Atorvastatin and Ezetimibe. J. Chromatogr. Sci. 2013, 51 (3), 222–228.
  • Sistla, R.; Tata, V. S.; Kashyap, Y. V.; Chandrasekar, D.; Diwan, P. V. Development and Validation of a Reversed-Phase HPLC Method for the Determination of Ezetimibe in Pharmaceutical Dosage Forms. J. Pharm. Biomed. Anal. 2005, 39 (3–4), 517–522.
  • Singh, S.; Singh, B.; Bahuguna, R.; Wadhwa, L.; Saxena, R. Stress Degradation Studies on Ezetimibe and Development of a Validated Stability-Indicating HPLC Assay. J. Pharm. Biomed. Anal. 2006, 41 (3), 1037–1040.
  • Dixit, R. P.; Barhate, C. R.; Padhye, S. G.; Viswanathan, C. L.; Nagarsenker, M. S. Stability Indicating RP-HPLC Method for Simultaneous Determination of Simvastatin and Ezetimibe from Tablet Dosage Form. Indian J. Pharm. Sci. 2010, 72 (2), 204–210.
  • Chaudhari, B. G.; Patel, N. M.; Shah, P. B. Stability-Indicating Reversed-Phase Liquid Chromatographic Method for Simultaneous Determination of Simvastatin and Ezetimibe from Their Combination Drug Products. J. AOAC Int. 2007, 90 (5), 1242–1249.
  • Doshi, A. S.; Kachhadia, P. K.; Joshi, H. S. Validation of a Stability-Indicating LC Method for Assay of Ezetimibe in Tablets and for Determination of Content Uniformity. Chromatographia 2008, 67 (1–2), 137–142.
  • Gajjar, A. K.; Shah, V. D. Isolation and Structure Elucidation of Major Alkaline Degradant of Ezetimibe. J. Pharm. Biomed. Anal. 2011, 55 (1), 225–229.
  • Özaltın, N.; Uçaktürk, E. Simultaneous Determination of Ezetimibe and Simvastatin in Pharmaceutical Formulations by Dual-Mode Gradient LC. Chromatographia 2007, 66 (S1), 87–91.
  • Sree Janardhanan, V.; Manavalan, R.; Valliappan, K. Chemometric Technique for the Optimization of Chromatographic System: Simultaneous HPLC Determination of Rosuvastatin, Telmisartan, Ezetimibe and Atorvastatin Used in Combined Cardiovascular Therapy. Arab. J. Chem. 2012, doi:10.1016/j.arabjc.2012.03.001.
  • Basha, S. J.; Naveed, S. A.; Tiwari, N. K.; Shashikumar, D.; Muzeeb, S.; Kumar, T. R.; Kumar, N. V.; Rao, N. P.; Srinivas, N.; Mullangi, R.; Srinivas, N. R. Concurrent Determination of Ezetimibe and Its Phase-I and II Metabolites by HPLC with UV Detection: Quantitative Application to Various In Vitro Metabolic Stability Studies and for Qualitative Estimation in Bile. J. Chromatogr. B 2007, 853 (1–2), 88–96.
  • Bahrami, G.; Mohammadi, B.; Khatabi, P. M.; Farzaei, M. H.; Majnooni, M. B.; Bahoosh, S. R. Application of One-Step Liquid Chromatography-Electrospray Tandem MS/MS and Collision-Induced Dissociation to Quantification of Ezetimibe and Identification of Its Glucuronated Metabolite in Human Serum: A Pharmacokinetic Study. J. Chromatogr. B 2010, 878 (28), 2789–2795.
  • Danafar, H.; Hamidi, M. A Rapid and Sensitive LC–MS Method for Determination of Ezetimibe Concentration in Human Plasma: Application to a Bioequivalence Study. Chromatographia 2013, 76 (23–24), 1667–1675.
  • Karanam, S. R.; Katakam, P.; Chandu, B. R.; Hwisa, N. T.; Adiki, S. K. Simultaneous Determination of Ezetimibe and Simvastatin in Rat Plasma by Stable-Isotope Dilution LC-ESI–MS/MS and Its Application to a Pharmacokinetic Study. J. Pharm. Anal. 2014, 4 (4), 286–294.
  • Oliveira, P. R.; Junior, L. B.; Fronza, M.; Bernardi, L. S.; Masiero, S. M. K.; Dalmora, S. L. Development and Validation of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Ezetimibe in Human Plasma and Pharmaceutical Formulations. Chromatographia 2006, 63 (7–8), 315–320.
  • Schmidt, A. H.; Molnár, I. Using an Innovative Quality-by-Design Approach for Development of a Stability Indicating UHPLC Method for Ebastine in the API and Pharmaceutical Formulations. J. Pharm. Biomed. Anal. 2013, 78–79, 65–74.
  • Awotwe-Otoo, D.; Agarabi, C.; Faustino, P. J.; Habib, M. J.; Lee, S.; Khan, M. A.; Shah, R. B. Application of Quality by Design Elements for the Development and Optimization of an Analytical Method for Protamine Sulfate. J. Pharm. Biomed. Anal. 2012, 62, 61–67.
  • Monks, K. E.; Rieger, H. J.; Molnár, I. Expanding the Term “Design Space” in High Performance Liquid Chromatography (I). J. Pharm. Biomed. Anal. 2011, 56 (5), 874–879.
  • International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Draft Step 4. Pharmaceutical Development Q8 (R2); ICH IFPMA: Geneva, 2009.
  • Orlandini, S.; Pinzauti, S.; Furlanetto, S. Application of Quality by Design to the Development of Analytical Separation Methods. Anal. Bioanal. Chem. 2013, 405 (2–3), 443–450.
  • Box, G. E. P.; Behnken, D. W. Some New Three Level Designs for the Study of Quantitative Variables. Technometrics 1960, 2, 455–475.
  • Bezerra, M. A.; Santelli, R. E.; Oliveira, E. P.; Villar, L. S.; Escaleira, L. A. Response Surface Methodology (RSM) as a Tool for Optimization in Analytical Chemistry. Talanta 2008, 76 (5), 965–977.
  • Hatambeygi, N.; Abedi, G.; Talebi, M. Method Development and Validation for Optimised Separation of Salicylic, Acetyl Salicylic and Ascorbic Acid in Pharmaceutical Formulations by Hydrophilic Interaction Chromatography and Response Surface Methodology. J. Chromatogr. A 2011, 1218 (35), 5995–6003.
  • Montgomery, D. C. Design and Analysis of Experiments, Wiley: Hoboken, NJ, 2013.
  • Lundstedt, T.; Seifert, E.; Abramo, L.; Thelin, B.; Nystrom, A.; Pettersen, J.; Bergman, R. Experimental Design and Optimization. Chemometrics. Intelligent Lab. Syst. 1998, 42, 3–40.
  • International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Draft Step 4. Validation of analytical text procedures: Text and methodology Q2 (R1); ICH: Geneva, 2005.
  • Rafamantanana, M. H.; Debrus, B.; Raoelison, G. E.; Rozet, E.; Lebrun, P.; Uverg-Ratsimamanga, S.; Hubert, P.; Quetin-Leclercq, J. Application of Design of Experiments and Design Space Methodology for the HPLC-UV Separation Optimization of Aporphine Alkaloids from Leaves of Spirospermum penduliflorum Thouars. J. Pharm. Biomed. Anal. 2012, 62, 23–32.
  • Snyder, L. R.; Kirkland, J. J.; Dolan, J. W. Introduction to Modern Liquid Chromatography, Wiley: Hoboken, NJ, 2010.
  • Derringer, G.; Suich, R. Simultaneous Optimization of Several Response Variables. J. Quality Technol. 1980, 12, 214–220.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.